【摘 要】
:
Late diagnosis and inadequate knowledge about tumor progression and its associated molecular alterations pose significant problems in the treatment of lung cancer patients.To this end, appropriate ani
【机 构】
:
Max Planck Institute for Heart and Lung Research Molecular Mechanisms in Lung Cancer Germany
【出 处】
:
BITs 3rd Annual World Cancer Congress-2012(2012第五届世界癌症大会)
论文部分内容阅读
Late diagnosis and inadequate knowledge about tumor progression and its associated molecular alterations pose significant problems in the treatment of lung cancer patients.To this end, appropriate animal models that mimic human disease paradigm in terms of genetic alterations and histological characteristics should be developed.Another significant problem in the treatment of lung cancer patients is late diagnosis.Nevertheless, a group of new techniques known collectively as "molecular imaging" now offers scientists an unprecedented opportunity to significantly improve the detection of localized lung cancer, better understand tumor biology, improve diagnosis, enhance treatment, and consequently reduce mortality.These approaches have the potential to identify small and early lesions that have not been readily detectable in clinical practice through more conventional methods.However, the resolution of conventional CT-systems is not sufficient for scanning and quantitative monitoring of lung disease in small animal models.Furthermore, the CT technique suffers from poor soft tissue resolution, though visualization of the lung tissue means imaging in high contrast.The recent development of high resolution CT imaging such as of micro computed tomography (micro-CT) has not solved the problem of poor contrast;however, the higher resolution makes the technique suitable for small animal imaging.Micro-CT systems provide resolution down to 10μm, but there is a trade-off between resolution, field of view, and radiation dose.The successful development of tumor models with human cell lines and the availability of novel therapeutic approaches like anti-angiogenic or genetic therapies increase the need for advancement in high resolution in vivo imaging in small animal models for tumor screening and volumetry.Beyond morphology at a definite time-point, follow-up studies play a critical role in cancer research.Therefore, imaging systems offering a high resolution in time and space have to be provided.
其他文献
BACKGROUND: Conventional neuromonitoring during thyroid surgery has reduced the injury rate of recurrent laryngeal nerve (RLN), but it is still at risk for damage.The feasibility of continuous RLN mon
The aim of this study is to demonstrate that, with the oncoplastic surgery technique that we propose, it is possible to make a breast-conserving surgery, yet oncologically radical for cancer, if not l
Well-differentiated thyroid cancer (DTC) has an overall good prognosis, although it frequently spreads locally and recurs by metastasizing to local cervical lymph nodes.The only curative treatment for
Background Endoscopic thyroidectomies have been performed using various approaches, and indications have expanded with the development of new surgical techniques and instruments.Endoscopic thyroid sur
Tumor genomes can be highly rearranged and non colinear with the host genome.Recurrent genome rearrangements involve genes that are increasingly targeted by anti-tumor therapeutics.Current technologie
A polymorphism at codon 72 of the p53 tumor suppressor gene is a possible determinant for cancer risk, particularly for carcinomas associated with HPV infection.We recently reported that high-risk HPV
Metastatic tumors are the most common intra-ocular malignancies and choroid is by far the most common site for intra-ocular malignancies.Multiple foci are usually involved, and bilateral involvement i
Introduction: Targeted therapy is going to be the mainstay treatment of cancer diseases.In the recent years, the utilization of geftinib, erlotinib and bevacizuamb on metastatic or unresectable non-sm
Carcinoma of the lung is the leading cause of death from malignancy in the United States.Twenty percent of patients with lung carcinoma are asymptomatic early in the course of the disease.Survival rat
Radiofrequency ablation (RFA) uses an electromagnetic wave with a frequency band and is a new treatment offered as a minimally invasive treatment.RFA is most commonly used to treat patients with liver